Aranesp’s Serious Risks Omitted in Marketing Piece
Anemia Drug Aranesp’s Serious Risks. Parker Waichman LLP is investigating a class action lawsuit over misleading marketing claims made by drug maker, Amgen Inc., regarding its anemia drug, Aranesp [...]